TNFSF13B and periodontitis: As shown in Fig. 3f, the anti-BAFF antibody-treated group with periodontitis (anti-BAFF-periodontitis group) showed significantly reduced alveolar bone resorption when compared with the periodontitis group treated with isotype control antibody (isotype-periodontitis group).